MoneyWorks4Me

Glenmark Pharmaceuticals submits media release

26 Nov 2019 Evaluate

Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Metformin Hydrochloride Extended?Release Tablets USP, 500 mg and 1000 mg’, which is self explanatory.  

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.20
Dr. Reddys Labs. 1177.90
Cipla 1297.85
Lupin 1954.15
Zydus Lifesciences 1117.75
View more..